Where can I find PYXS's financial statements?

Pyxis Oncology, Inc. (PYXS)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for PYXS?

Pyxis Oncology, Inc. (PYXS) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does PYXS update its statements?

Pyxis Oncology, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

PYXS

Pyxis Oncology, Inc.

NASDAQ·Biotechnology · Healthcare

$3.34$0.28+9.15%

After hours·$3.33−0.30%

Market cap$211.61M·Market closed·Aug 26 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Trend
Revenue	$0.00	$0.00	$0.00	$16.15M	$13.86M−14.2%
Cost of revenue	—	—	—	$475.00K	$2.39M+402.7%
Gross profit	$0.00+100.0%	$0.00	$0.00	$15.67M	$11.47M−26.8%
Research & development	$51.05M+493.4%	$86.13M+68.7%	$49.59M−42.4%	$58.75M+18.5%	$73.70M+25.4%
General & administrative	$18.66M	$37.35M+100.1%	$32.61M−12.7%	$25.42M−22.0%	$22.19M−12.7%
SG&A (combined)	$18.66M+385.3%	$37.35M+100.1%	$32.61M−12.7%	$25.42M−22.0%	$22.19M−12.7%
Other operating expenses	—	—	—	$20.96M	—	—
Total operating expenses	$69.72M+460.0%	$123.48M+77.1%	$82.20M−33.4%	$105.13M+27.9%	$95.89M−8.8%
Operating income	−$69.72M−440.7%	−$123.48M−77.1%	−$82.20M+33.4%	−$89.46M−8.8%	−$84.42M+5.6%
Interest income	$23.00K−65.2%	$2.76M+11,917.4%	$6.63M+139.9%	$7.04M+6.2%	$3.61M−48.7%
Other income / (expense), net	−$6.26M−9,581.8%	$2.76M+144.2%	$8.41M+204.1%	$9.97M+18.5%	$6.19M−37.9%
Income before tax	−$75.98M−492.3%	−$120.72M−58.9%	−$73.79M+38.9%	−$79.50M−7.7%	−$78.24M+1.6%
Income tax expense	—	—	—	−$2.16M	$1.39M+164.0%
Net income	−$75.98M−492.3%	−$120.72M−58.9%	−$73.79M+38.9%	−$77.33M−4.8%	−$79.62M−3.0%

EPS (basic)	−$2.53−583.8%	−$3.57−41.1%	−$1.85+48.2%	−$1.32+28.6%	−$1.28+3.0%
EPS (diluted)	−$2.53−583.8%	−$3.57−41.1%	−$1.85+48.2%	−$1.32+28.6%	−$1.28+3.0%
Weighted avg shares (basic)	32,222,881	33,033,081	39,904,603	58,445,765	62,143,166
Weighted avg shares (diluted)	32,222,881	33,033,081	39,904,603	58,445,765	62,143,166

Depreciation & amortization	$647.00K+45.7%	$709.00K+9.6%	$1.93M+171.8%	$2.98M+54.7%	$4.51M+51.3%
EBITDA	−$75.33M−508.3%	−$120.01M−59.3%	−$71.86M+40.1%	−$65.51M+8.8%	−$73.72M−12.5%

Frequently Asked Questions About PYXS

Where can I find PYXS's financial statements?: Pyxis Oncology, Inc. (PYXS)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for PYXS?: Pyxis Oncology, Inc. (PYXS) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does PYXS update its statements?: Pyxis Oncology, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.